↓ Skip to main content

Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials

Overview of attention for article published in Health and Quality of Life Outcomes, November 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials
Published in
Health and Quality of Life Outcomes, November 2019
DOI 10.1186/s12955-019-1242-6
Pubmed ID
Authors

Gian Luca Di Tanna, Joshua K. Porter, Richard B. Lipton, Anthony J. Hatswell, Sandhya Sapra, Guillermo Villa

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 12%
Student > Ph. D. Student 6 12%
Student > Master 6 12%
Researcher 5 10%
Student > Doctoral Student 3 6%
Other 7 13%
Unknown 19 37%
Readers by discipline Count As %
Medicine and Dentistry 14 27%
Pharmacology, Toxicology and Pharmaceutical Science 7 13%
Nursing and Health Professions 4 8%
Neuroscience 2 4%
Business, Management and Accounting 1 2%
Other 4 8%
Unknown 20 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2021.
All research outputs
#2,706,521
of 23,172,045 outputs
Outputs from Health and Quality of Life Outcomes
#196
of 2,191 outputs
Outputs of similar age
#58,342
of 359,983 outputs
Outputs of similar age from Health and Quality of Life Outcomes
#2
of 27 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,191 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,983 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.